Home Investors News Press Releases 2003

If you would like to be alerted when a press release is added to this site, please register with the Alerting Service.

Select a month	AllJanuary February March April May June July August September October November December
Select a year	All2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Search for:

12/05/2003	Cyclacel Announces In-Licensing Of Phase I Anticancer Drug From Sankyo
11/20/2003	Cyclacel Reports Interim CYC202 Phase I Data In Patients With Advanced Cancer
11/18/2003	Cyclacel Announces Discovery Of Novel Anticancer Drugs Inhibiting Plk1
11/14/2003	CYC202 Beneficial Effects In Kidney Disease Models Reported In Major Nephrology Conference
10/09/2003	Cyclacel And MRC geneservice Sign Distribution Agreement For Drosophila Genome RNAi Collection
09/24/2003	Cyclacel In-Licenses Novel Anticancer Drug From Lorus Therapeutics
07/14/2003	Cyclacel’s Biomarker Technology Shows That CYC202 Induces Cancer Cells To Commit Suicide
05/22/2003	Cyclacel Reports Progress In Second Generation CDK Inhibitor Programme
03/31/2003	Cyclacel Announces RNAi Collaboration
01/27/2003	Cyclacel Appoints Professor Karol Sikora To Cancer Scientific Advisory Board
1  2    >>

  Go to top      Print page